YEAR
- 2017.12.13 Identification of MYLK3 mutations in familial dilated cardiomyopathy. Tobita T, Nomura S, Morita H, Ko T, Fujita T, Toko H, Uto K, Hagiwara N, Aburatani H, Komuro I.Sci Rep. 2017 12 13;7(1):17495. doi: 10.1038/s41598-017-17769-1
- 2017.03.07 Genetic and epigenetic stability of oligodendrogliomas at recurrence. Aihara K, Mukasa A, Nagae G, Nomura M, Yamamoto S, Ueda H, Tatsuno K, Shibahara J, Takahashi M, Momose T, Tanaka S, Takayanagi S, Yanagisawa S, Nejo T, Takahashi S, Omata M, Otani R, Saito K, Narita Y, Nagane M, Nishikawa R, Ueki K, Aburatani H, Saito N.Acta Neuropathol Commun. 2017 03 07;5(1):18. doi: 10.1186/s40478-017-0422-z
- 2017.04.10 Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2. Nagata N, Iwanari H, Kumagai H, Kusano-Arai O, Ikeda Y, Aritake K, Hamakubo T, Urade Y.PLoS ONE. 2017;12(4):e0175452. doi: 10.1371/journal.pone.0175452
- 2017.09.06 Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis. Sarashina-Kida H, Negishi H, Nishio J, Suda W, Nakajima Y, Yasui-Kato M, Iwaisako K, Kang S, Endo N, Yanai H, Asagiri M, Kida H, Hattori M, Kumanogoh A, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2017 09 19;114(38):10178-10183. doi: 10.1073/pnas.1712837114
- 2017.09.19 Fine-tuning type I IFN signaling: A new chapter in the IFN saga. Yanai H, Taniguchi T.Cell Res. 2017 12;27(12):1407-1408. doi: 10.1038/cr.2017.118
- 2017.02.28 Extracellular Acidic pH Activates the Sterol Regulatory Element-Binding Protein 2 to Promote Tumor Progression. Kondo A, Yamamoto S, Nakaki R, Shimamura T, Hamakubo T, Sakai J, Kodama T, Yoshida T, Aburatani H, Osawa T.Cell Rep. 2017 02 28;18(9):2228-2242. doi: 10.1016/j.celrep.2017.02.006
- 2017.05.25 Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells. Matsusaka K, Funata S, Fukuyo M, Seto Y, Aburatani H, Fukayama M, Kaneda A.J. Pathol. 2017 08;242(4):391-399. doi: 10.1002/path.4909
- 2017.03.06 Epiregulin-blocking antibody inhibits epiregulin-dependent EGFR signaling. Iijima M, Anai M, Kodama T, Shibasaki Y.Biochem. Biophys. Res. Commun. 2017 07 15;489(1):83-88. doi: 10.1016/j.bbrc.2017.03.006
CLOSE